Microglia: proliferation and activation driven by the P2X7 receptor.

[1]  J. Lucas,et al.  Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  C. Reid,et al.  The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore , 2009, The Journal of Neuroscience.

[3]  F. Conquet,et al.  Up-Regulation of P2X4 Receptors in Spinal Microglia after Peripheral Nerve Injury Mediates BDNF Release and Neuropathic Pain , 2008, The Journal of Neuroscience.

[4]  H. Le Stunff,et al.  P2X7 receptor-mediated phosphatidic acid production delays ATP-induced pore opening and cytolysis of RAW 264.7 macrophages. , 2007, Cellular signalling.

[5]  Hyun B Choi,et al.  Modulation of the Purinergic P2X7 Receptor Attenuates Lipopolysaccharide-Mediated Microglial Activation and Neuronal Damage in Inflamed Brain , 2007, The Journal of Neuroscience.

[6]  K. Jacobson,et al.  UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis , 2007, Nature.

[7]  W. Gan,et al.  The P2Y12 receptor regulates microglial activation by extracellular nucleotides , 2006, Nature Neuroscience.

[8]  F. Di Virgilio,et al.  A role for P2X7 in microglial proliferation , 2006, Journal of neurochemistry.

[9]  Hyun B Choi,et al.  Upregulated Expression of Purinergic P2X7 Receptor in Alzheimer Disease and Amyloid-&bgr; Peptide-Treated Microglia and in Peptide-Injected Rat Hippocampus , 2006, Journal of neuropathology and experimental neurology.

[10]  T. Joh,et al.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.

[11]  P. Anand,et al.  COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord , 2006, BMC neurology.

[12]  G. Burnstock,et al.  Microglial morphology and its transformation after challenge by extracellular ATP in vitro , 2006, Journal of neuroscience research.

[13]  F. Helmchen,et al.  Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.

[14]  Kazuhide Inoue,et al.  Production and Release of Neuroprotective Tumor Necrosis Factor by P2X7 Receptor-Activated Microglia , 2004, The Journal of Neuroscience.

[15]  S. Koizumi,et al.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.

[16]  H. Korf,et al.  The bisphosphonate clodronate depletes microglial cells in excitotoxically injured organotypic hippocampal slice cultures , 2003, Experimental Neurology.

[17]  B. Robertson,et al.  P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease* , 2003, The Journal of Biological Chemistry.

[18]  W. Dietrich,et al.  Inflammatory Mechanisms after Ischemia and Stroke , 2003, Journal of neuropathology and experimental neurology.

[19]  G. Garden Microglia in human immunodeficiency virus‐associated neurodegeneration , 2002, Glia.

[20]  E. Cavalheiro,et al.  Evidence That ATP Participates in the Pathophysiology of Pilocarpine‐Induced Temporal Lobe Epilepsy: A Fluorimetric, Immunohistochemical, and Western Blot Studies , 2002, Epilepsia.

[21]  A. Hao,et al.  Origin of microglia , 2001, Microscopy research and technique.

[22]  A. Reichenbach,et al.  Upregulation of P2X(7) receptor currents in Müller glial cells during proliferative vitreoretinopathy. , 2001, Investigative ophthalmology & visual science.

[23]  F. Di Virgilio,et al.  Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor* , 1999, The Journal of Biological Chemistry.

[24]  Hua Yu,et al.  Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis , 1999, Journal of Neuroimmunology.

[25]  M. Gurney,et al.  Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .

[26]  F. Virgilio ATP as a death factor , 1998, BioFactors.

[27]  E. Kawashima,et al.  Tissue distribution of the P2X7 receptor , 1997, Neuropharmacology.

[28]  D. Ferrari,et al.  Spontaneous Cell Fusion in Macrophage Cultures Expressing High Levels of the P2Z/P2X7 Receptor , 1997, The Journal of cell biology.

[29]  Stefania Hanau,et al.  Purinergic Modulation of Interleukin-1 ␤ Release from Microglial Cells Stimulated with Bacterial Endotoxin Materials and Methods , 1997 .

[30]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[31]  I. Black,et al.  Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  I. Schieren,et al.  P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. , 1994, Blood.

[33]  K. Williams,et al.  Induction of primary T cell responses by human glial cells , 1993, Journal of neuroscience research.

[34]  W. Streit,et al.  A chronicle of microglial ontogeny , 1993, Glia.

[35]  K. Boje,et al.  Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death , 1992, Brain Research.

[36]  N. Takei,et al.  Production of basic fibroblast growth factor in cultured rat brain microglia , 1991, Neuroscience Letters.

[37]  J. Scholes,et al.  Diversity amongst the microglia in growing and regenerating fish CNS: Immunohistochemical characterization using FL. 1, an anti‐macrophage monoclonal antibody , 1991, Glia.

[38]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[39]  V. Perry,et al.  Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain , 1985, Neuroscience.